Active Pharmaceutical Ingredient (API) Prequalified
M
Molnupiravir manufactured by Aurore Life Sciences Private Limited has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
News
Active Pharmaceutical Ingredient (API) Prequalified
M
Tranexamic acid manufactured by Ami Lifesciences Private Limited has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.
Shanghai Fosun’s nirmatrelvir + ritonavir tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Indoco’s chewable albendazole tablets prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Shijiazhuang Lonzeal’s tenofovir disoproxil against hepatitis prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Lupin’s rifampicin/isoniazid/pyrazinamide dispersible tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Swiss Pharma Nigeria’s sulfadoxine/pyimethamine tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
First chewable albendazole prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Lupin’s rifapentine tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Emcure’s dolutegravir/lamivudine/tenofovir tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Shanghai Desano’s molnupiravir capsule prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Shanghai Fosun’s molnupiravir capsule prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
WHO prequalifies the first self-test for hepatitis C virus
IVD
10 July 2024 – The World Health Organization (WHO) has preq
Shanghai Desano's ritonavir tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Reyoung Pharmaceutical's sulfamethoxazole/trimethoprim tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
WHO PQT-IVD Webinar – New Applicants to IVD Prequalification
IVD
A webinar for IVD manufacturers was held on 26 June.
REGISTRATION OPEN: 2024 annual joint UNICEF-UNFPA-WHO meeting with manufacturers and suppliers
IVD
Dear Colleagues,
WHO PQT-IVD Webinar – Product Dossier Assessment
IVD
A webinar for IVD manufacturers was held on Wednesday 29 May to share information about prequalificati
Performance evaluations for IVDs for monitoring of blood glucose in capillary blood and HbA1c PoC Assays
IVD
On 12 April 2024 WHO announced the expansion of prequalification of in vitro diagnostics to include diabetes.
Macleods’ artesunate 120 mg for injection prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Mylan’s molnupiravir prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
HIV/AIDS EOI revised
M
The following products were added:
S Kant’s sulfadoxine/pyrimethamine tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Ipca’s pyrimethamine/sulfadoxine dispersible tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Ipca’s pyrimethamine/sulfadoxine dispersible tabl + amodiaquine dispersible tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Macleods’ flucytosine tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
S Kant’s dispersible isoniazid tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list: